Clinical Trial Update: Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of dutogliptin added to pioglitazone in type 2 diabetes mellitus has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dutogliptin (dutogliptin)
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Forest Laboratories | Conditions: Diabetes Mellitus, Type II | Phase 3 | Status: TERMINATED